New drug targeting LF and onchocerciasis begins its first in

A new drug developed by an LSTM led partnership, which targets the neglected tropical diseases lymphatic filariasis and onchocerciasis has begun its first in human trial.

Related Keywords

United Kingdom , Paul Oneill , Mark Taylor , Emily Henderson , Liverpool University Hospitals , Melinda Gates Foundation , Eisai Co , Foundation Trust On , Global Health Innovative Technology , University Of Liverpool , Department Of Chemistry , Broadgreen Clinical Research Facility , Professor Steve Ward , Onchocerciasis , Drugs , Filariasis , Lymphatic Filariasis , Medicine , Olecule , Reclinical , Wolbachia ,